Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-002811
Filing Date
2025-01-07
Accepted
2025-01-07 16:00:03
Documents
1
Period of Report
2025-01-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 9711
  Complete submission text file 0000950170-25-002811.txt   11233
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Issuer) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O GALECTO, INC. OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200
Business Address
Schambye Hans T. (Reporting) CIK: 0001825776 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39655 | Film No.: 25514793